The potential benefits of gene therapy for neurological diseases such as Parkinson's, Amyotrophic Lateral Sclerosis (ALS), Epilepsy, and Alzheimer's are enormous. Even a delay in the onset of severe symptoms would be invaluable to patients suffering from these and other diseases. Significant effort has been placed in developing vectors capable of delivering therapeutic genes to the CNS in order to treat neurological disorders. At the forefront of potential vectors, viral systems have evolved to efficiently deliver their genetic material to a cell. The biology of different viruses offers unique solutions to the challenges of gene therapy, such as cell targeting, transgene expression and vector production. It is important to consider the natural biology of a vector when deciding whether it will be the most effective for a specific therapeutic function. In this review, we outline desired features of the ideal vector for gene delivery to the CNS and discuss how well available viral vectors compare to this model. Adeno-associated virus, retrovirus, adenovirus and herpesvirus vectors are covered. Focus is placed on features of the natural biology that have made these viruses effective tools for gene delivery with emphasis on their application in the CNS. Our goal is to provide insight into features of the optimal vector and which viral vectors can provide these features.
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Introduction: viruses as vectors for therapeutic gene delivery
The idea to treat human disease by delivering a therapeutic gene was first conceived as early as the 1970s (Friedmann and Roblin, 1972) . The potential of viruses as vectors for gene delivery was recognized even then. Viruses are among the simplest biological agents capable of delivering genetic information to a cell and have evolved properties that make them useful as vectors for gene delivery (Shen and Post, 2007) . Structural virions carry and protect viral genetic information (DNA and RNA), providing stability for transit throughout the human body. Determinants on the surface of the virion specify which cells the virus will enter while minimizing immunostimulatory potential within the host. Signals in the genetic material control gene expression from the virus in the infected cell. Finally, many viruses have developed mechanisms of replication that allow them to be propagated in cell culture. Though these innate properties have been advantageous in developing vectors for gene delivery, using viruses comes with potential risks as well. Many viruses cause disease and vectors derived from them have the potential to be pathogenic. The goal in designing vectors is to minimize this potential risk by using only components of the virus necessary for transduction of the target cell and expression of the transgene, while also preserving the efficiency of production. In this review, features of the ideal vector for delivering genes to the CNS are outlined. We then discuss the molecular biology of several viruses currently being developed as vectors and how Neurobiology of Disease 48 (2012) 179-188 
